In summary, all analyzed biomarkers—neutrophil elastase, elafin and the NE/elafin ratio-demonstrated significant potential for the diagnosis of both ulcerative colitis and Crohn’s disease. This evidence concerns the gene PI3 and ulcerative colitis.